Case Report: Anlotinib combined with radiotherapy achieves sustained disease control in advanced malignant melanotic nerve sheath tumor | Synapse
March 3, 2026Open Access
Case Report: Anlotinib combined with radiotherapy achieves sustained disease control in advanced malignant melanotic nerve sheath tumor
Key Points
Anlotinib combined with radiotherapy achieved sustained disease control in advanced malignant melanotic nerve sheath tumor.
The combination therapy provides effective management, potentially improving outcomes for patients with this rare malignancy.
Analysis focused on an advanced malignant melanotic nerve sheath tumor, showing positive effects of the combined treatment.
The findings suggest further exploration of this therapeutic option may enhance treatment strategies for similar tumors.
Abstract
This case suggests that anlotinib combined with radiotherapy may be an effective therapeutic option for advanced MMNST, providing valuable clinical evidence for managing this malignancy.